Session | Tuberculosis in children

Session | Tuberculosis in children

🎙 Epicentre - MSF 👥 737 📅 June 15, 2026 ⏱ 71 min 👁 13 📄 original study 🧭 2026-08-16
Available in: English (current) Français

Keywords

tuberculosischildrendiagnosisalgorithmCADSAMTB LAMMSF

Summary

This scientific session, part of Epicentre’s 40th anniversary, focuses on tuberculosis (TB) in children. The moderator introduces MSF’s historical research on TB, highlighting key studies and their impact on global guidelines. The first presentation by Dr. Muhammad Bashier Abdulahi details the TB ALGO study, a multi-country observational study validating WHO’s treatment decision algorithms (TDAs) for diagnosing TB in children with severe acute malnutrition (SAM). Results show that clinical scoring is the main reason for treatment initiation, with high sensitivity (84%) and acceptable specificity (85%). A nested study on TB LAM tests in HIV-negative children with SAM found that the Determine TB LAM had low specificity, while FujiLAM showed high specificity, suggesting potential as a rule-in test. The second presentation by Juno Min evaluates computer-aided detection (CAD) for chest X-ray interpretation in children. The study, part of the TB ALGO study, included 665 children and found an overall AUC of 0.76, indicating fair performance. Performance varied by site, with AUCs ranging from 0.68 to 0.87. The session concludes with a Q&A, emphasizing the importance of operational research in improving pediatric TB diagnosis and care.

183 words

Critical Evaluation

Value of the Information & Strength of the Argument

The session provides valuable insights into the challenges of diagnosing TB in children, particularly in resource-limited settings. The presentations are based on original research from the TACTIC project, with robust methodologies including multi-country cohorts and reference standards. The argumentation is solid, supported by data and references to WHO guidelines. The speakers effectively highlight the practical implications of their findings for clinical practice and policy. The discussion on CAD technology is particularly valuable, addressing a gap in current recommendations and providing evidence for potential use in children. Overall, the information is highly relevant for clinicians, researchers, and policymakers working on pediatric TB.

Scientific Rigor, Source Quality, Title Accuracy

The session demonstrates strong scientific rigor, with studies designed to validate WHO algorithms and assess new diagnostic tools. The sources cited include WHO guidelines and the studies themselves, which are part of the TACTIC project. The title accurately reflects the content, focusing on TB in children. The presentations are well-structured, with clear objectives, methods, results, and conclusions. The use of reference standards and ROC analysis adds to the credibility. However, the video is a recording of a live session, and some details may be omitted. The lack of peer-reviewed publication references for the specific studies presented is a minor limitation. Overall, the scientific quality is high, and the title-content alignment is excellent.

228 words

Title / Content Match

The title accurately reflects the content, which focuses on tuberculosis in children, covering diagnostic algorithms, AI-based CAD, and research findings.

Quality & Reliability

8/10

The session presents original research from MSF's TACTIC project, with detailed methodology and results from two studies on pediatric TB diagnosis. The content is grounded in WHO guidelines and includes expert speakers. However, the video is a recording of a scientific session, and the data presented are preliminary or from specific contexts, limiting generalizability. The lack of peer-reviewed publication details and the small number of views/comments reduce the overall reliability score.

Key Moments

Cited Sources

  • WHO treatment decision algorithms for TB in children — Mentioned as the basis for the TB ALGO study validation.
  • TACTIC project — Described as the initiative funding the studies presented.

Concurring Sources

  • WHO treatment decision algorithms for TB in children — The study validates these algorithms, and the results are consistent with the need for clinical scoring.

Dissenting Sources

  • WHO recommendation on CAD for TB in adults — The study suggests CAD may be useful in children, but WHO currently recommends it only for individuals aged 15 and above.

Contribution & Novelties

This session provides original data on the validation of WHO treatment decision algorithms for TB in children with SAM, showing high sensitivity and acceptable specificity. It also evaluates the performance of TB LAM tests in HIV-negative children, finding that FujiLAM may have potential as a rule-in test. Additionally, it assesses the use of CAD for chest X-ray interpretation in children, an area not yet recommended by WHO, providing evidence for its potential utility. These findings contribute to improving pediatric TB diagnosis in resource-limited settings.

Pour aller plus loin :

  • WHO guidelines on TB in children — Official guidelines that the studies aim to validate.
  • Computer-aided detection for TB — WHO recommendations on CAD for TB screening in adults.
  • TB LAM testing — WHO guidelines on the use of TB LAM assays.

131 words

Radar Profile

The radar profile shows high scores in information quantity, quality, and technical level, with a slightly lower but still strong reliability score. This indicates a scientifically robust session with substantial content, though the reliability is tempered by the preliminary nature of the research and lack of peer-reviewed publication details.

Reliability 8/10

💬 No comments were provided for analysis.